more

Waters (WAT)

(Delayed Data from NYSE)

$305.31 USD

+4.48 (1.49%)

Updated Jul 24, 2024 04:00 PM ET

After-Market: $305.53 +0.22 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	17.88%
3	Hold	9.47%
4	Sell	5.14%
5	Strong Sell	2.57%
S&P	500	11.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5 4

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum C VGM

Industry Rank:

Top 40% (100 out of 250)

Industry: Medical - Instruments

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.

Can Strong Memory Save Lam Research (LRCX) in Q3 Earnings?

by Zacks Equity Research Published on April 13,2018

Lam Research's (LRCX) third-quarter results are likely to benefit from the strong memory market and shipments. However, volatility in the PC market remains a concern.

Why Is Waters Corporation (WAT) Down 4.7% Since its Last Earnings Report?

by Zacks Equity Research Published on February 22,2018

Waters Corporation (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

WATPositive Net Change

Waters' (WAT) Q4 Earnings Beat on Broad-Based Sales Growth

by Zacks Equity Research Published on January 23,2018

Waters Corp.'s (WAT) fourth-quarter 2017 earnings beat driven by broad-based top-line expansion, along with spectacular growth in Europe.

Waters Corp. (WAT) Q4 Earnings, Revenues Beat Estimates

by Zacks Equity Research Published on January 23,2018

Waters Corp. (WAT) fourth-quarter earnings beat estimates comfortably, and revenues grew year over year.

WATPositive Net Change

What's in the Offing for Waters Corp (WAT) in Q4 Earnings?

by Zacks Equity Research Published on January 19,2018

High R&D and interest expenses are expected to hurt Waters Corp.'s (WAT) profitability in the quarter to be reported.

Here's Why Investing In Waters Corp (WAT) Now Makes Sense

by Zacks Equity Research Published on January 03,2018

Steady demand from pharmaceutical business, solid recurring revenues and modest recovery in industrial markets are proving conducive to Waters Corp's (WAT) impressive performance.

Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth

by Zacks Equity Research Published on October 24,2017

Waters Corp's (WAT) third-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Europe.

Waters Corp. (WAT) Q3 Earnings Beat Estimates, Sales Strong

by Zacks Equity Research Published on October 24,2017

Waters Corp. (WAT) third-quarter earnings beat estimates comfortably, and revenues grew year over year.

WATPositive Net Change

Why Waters (WAT) Might Surprise This Earnings Season

by Zacks Equity Research Published on October 23,2017

Waters (WAT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

WATPositive Net Change

Why Waters Corp (WAT) Looks Set to Beat on Q3 Earnings

by Zacks Equity Research Published on October 19,2017

Waters Corp (WAT) expects to beat third-quarter 2017 earnings on the back of steady demand from pharmaceutical business, growth in recurring revenues and modest recovery of industrial markets.

Why Is Waters (WAT) Down 2.1% Since the Last Earnings Report?

by Zacks Equity Research Published on August 25,2017

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

WATPositive Net Change

Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth

by Zacks Equity Research Published on July 25,2017

Waters Corp. (WAT) second-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Asia.

Waters Corp. (WAT) Q2 Earnings Beat Estimates, Sales Up Y/Y

by Zacks Equity Research Published on July 25,2017

Waters Corp. (WAT) second-quarter earnings beat estimates comfortably, and revenues grew year over year.

WATPositive Net Change

Why Earnings Season Could Be Great for Waters Corporation (WAT)

by Zacks Equity Research Published on July 24,2017

Investors might want to consider this stock ahead of earnings Given that Waters Corporation (WAT) has a Zacks Rank #2 (Buy) and an ESP in positive territory.

WATPositive Net Change

What to Expect from Shutterfly (SFLY) this Earnings Season?

by Zacks Equity Research Published on July 21,2017

Improved operational efficiency and expansion of its range of products is expected to enhance Shutterfly, Inc.'s (SFLY) second-quarter performance, while higher costs might mar the same.

Why an Earnings Beat is Likely for Waters Corp. (WAT) in Q2

by Zacks Equity Research Published on July 21,2017

Waters Corp.'s (WAT) dominant position in the biopharma end markets and thriving sales in emerging markets will likely help it gain traction in the second quarter.